Nothing else is going on, so here’s a really shallow Hall of Fame thought:
I think it’s almost certain — like, 99.9% certain — that there is already a member of the Hall of Fame who used performance enhancing drugs. Not just greenies, but 1980s-90s-2000s-style steroids, HGH and all of that stuff that causes everyone so much consternation. I even have a couple of ideas of players who may have — guys who aren’t normally mentioned in these conversations — though I won’t say their names for risk that someone take my baseless speculation as some sort of actual information, which it is not.
But if I had a genie who granted me three wishes, I’d use one of the wishes to wish for a million more wishes. Then, with one of those million more wishes, I’d wish that one of those Hall of Fame players announce today that, yes, he was juiced to the gills. No apologies, no explanations, just a “yeah, I was totally ‘roided up,” after which he drops the mic and goes back to hunting, fishing, signing autographs and whatever else he does in his retirement.
Wouldn’t it just make everyone’s head explode?
And while it is a shallow thought, it’s not just some hypothetical thing. Because one day we’re going to learn about a Hall of Famer who used PEDs, at which point one of the leading arguments against voting in the Barry Bonds and Roger Clemens of the world is going to make even less sense than it already does.
The Rangers will not sign free agent reliever Seung-hwan Oh after all. Reports from MLB.com’s TR Sullivan indicate that negotiations were brought to a halt after a physical issue was found with the pitcher. While the specifics have yet to be released, Evan Grant of the Dallas Morning News says the issue was revealed on an MRI of the right-hander’s arm.
Oh was thought to be in talks with the Rangers last week, though a deal was never officially announced by the club. The 35-year-old righty is fresh off of a two-year run with the Cardinals, during which he posted a cumulative 39 saves, 2.85 ERA, 2.1 BB/9 and 10.2 SO/9 in 139 innings. He struggled with consistency in his sophomore season, however, and finished 2017 with a disappointing 4.10 ERA and 4.44 FIP in 62 appearances for the team.
While Oh hasn’t experienced any setbacks with his arm in the majors so far, he does have a history of prior injuries during his time in KBO. He sustained a shoulder injury in 2009 and underwent surgery to remove bone spurs from his elbow in 2010. It’s possible that the Rangers saw an entirely different problem on the MRI, but clearly it was enough to give them strong reservations about inking the righty to a $2.75+ million deal. It’s still possible that another of Oh’s suitors will offer him a contract prior to Opening Day; the Giants were rumored to be interested in the veteran reliever, among other teams, though their recent acquisition of lefty reliever Tony Watson will likely take them out of the running now.